메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Sandra Villanueva (Universidad de Los Andes Santiago Chile) Fernando González (Department of Nephrology Hospital Salvador Santiago Chile) Eduardo Lorca (Department of Nephrology Hospital Salvador Santiago Chile) Andrés Tapia (Universidad de Los Andes Santiago Chile) Valentina López G (Universidad de Los Andes Santiago Chile) Rocío Strodthoff (Faculty of Medicine Universidad de Los Andes Santiago Chile) Francisca Fajre (Faculty of Medicine Universidad de Los Andes Santiago Chile) Juan E. Carreño (Faculty of Medicine Universidad de Los Andes Santiago Chile) Ricardo Valjalo (Department of Nephrology Hospital Salvador Santiago Chile) César Vergara (Faculty of Medicine Universidad de Los Andes Santiago Chile) Manuel Lecanda (aculty of Medicine Universidad de Los Andes Santiago Chile) Jorge Bartolucci (Universidad de Los Andes Santiago Chile) Fernando E. Figueroa (Faculty of Medicine Universidad de Los Andes Santiago Chile) Maroun Khoury (Faculty of Medicine Universidad de Los Andes Santiago Chile)
저널정보
대한신장학회 Kidney Research and Clinical Practice Kidney Research and Clinical Practice Vol.38 No.2
발행연도
2019.1
수록면
176 - 185 (10page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Chronic kidney disease (CKD) is a growing public health concern, and available treatments are insufficient in limiting disease progression. New strategies, including regenerative cell-based therapies, have emerged as therapeutic alternatives. Results from several groups, including our own, have reported evidence of a supportive role for mesenchymal stromal cells (MSCs) in functional recovery and prevention of tissue damage in murine models of CKD. Prompted by these data, an open pilot study was conducted to assess the safety and efficacy of a single injection of autologous adipose tissue-derived MSCs (AT-MSCs) for treatment of CKD. Methods: AT-MSCs were infused intravenously into six CKD patients at a dose of 1 million cells/kg. Patients were stabilized and followed for one year prior to MSC infusion and one year following infusion. Results: No patients presented with adverse effects. Statistically significant improvement in urinary protein excretion was observed in AT-MSCs transplanted patients, from a median of 0.75 g/day (range, 0.15-9.57) at baseline to 0.54 g/day (range, 0.01-2.66) at month 12 (P = 0.046). The glomerular filtration rate was not significantly decreased post-infusion of AT-MSCs. Conclusion: Findings from this pilot study demonstrate that intravenous infusion of autologous expanded AT-MSCs into CKD patients was not associated with adverse effects and could benefit patients already undergoing standard medical treatment.

목차

등록된 정보가 없습니다.

참고문헌 (39)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0